NIH clarified New and Early Stage Investigator policies and established
comparable success rates for New and Established investigators on Type 1 (new) R01 Equivalent applications. It also indicated that half of the New Investigator pool each year should be Early Stage Investigators. Compliance was encouraged by developing and sending frequent status reports to the funding NIH institutes and centers during the course of each fiscal year. This also ended the period of using a five-year rolling average of New Investigators as the New Investigator target for future years.